Wells Fargo analyst Mike Mayo maintained a Buy rating on Citigroup (C – Research Report) today and set a price target of $95.00. The ...

Producers of dynamic random access memory, or DRAM, which includes Micron Technology, Samsung and SK Hynix, should see ...

Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.

Large Cap financials underperformed for much of the last two years The biggest banks also have strong brokerage units ...

Citi raised the firm’s price target on Air Products (APD) to $365 from $345 and keeps a Buy rating on the shares. The firm assumes a gradual ramp in earnings throughout the year on typical ...

Following Venture Corporation’s 3QFY2024 ended Sept results, Citi Research analyst Arthur Pineda has downgraded ... be flat ...

Fintel reports that on November 8, 2024, Citigroup upgraded their outlook for Chewy (NYSE:CHWY) from Neutral to Buy. Analyst ...

Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), ...

The company has a Momentum Grade of C, based on its Momentum Score of 49. This means that the stock’s momentum is average in ...

Many or all of the products on this page are from partners who compensate us when you click to or take an action on their website, but this does not influence our evaluations or ratings.

The new Citigold Private Client World Elite Debit Mastercard is designed to support globe-trotting lifestyles.  Read more at ...

For Citi, the economic and structural reforms enable us to bring more sophisticated financial products to market and help our clients access global capital markets more efficiently. The government’s ...